EUVIMEDEUVIMED entdecken
Crossref

Peroxisome depletion suppresses clear cell renal cell carcinoma

Tanja Eberhart, Lidia Madrigal Orriols, Vanessa Suter, Francesc Castro-Giner, Christophe D Chabbert, Jianwen Zhou, Nicola Zamboni, Jiong Hu, Harald C Köfeler, Nicola Aceto, Werner J Kovacs

Kidney International · 2026-11

DOI: 10.1016/j.kint.2026.10.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International, 2026-11. Verfasst von Tanja Eberhart und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland; Present address: Research Center Molecular Biotechnology, Hochschule Campus …. Die Arbeit nennt 146 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Clear cell renal cell carcinoma (ccRCC), the most common subtype of RCC, is characterized by constitutive activation of hypoxia-inducible factors (HIF-1α and HIF-2α), with HIF-2α promoting peroxisome turnover. Although peroxisomes play key roles in lipid metabolism and reactive oxygen species homeostasis, they remain relatively understudied in cancer research, and their contribution to ccRCC is poorly understood. Notably, peroxisome abundance is more frequently reduced in low-grade than in high-grade tumors, suggesting a potential role in tumorigenesis. METHODS: Peroxisome depletion was induced by impairing peroxisome biogenesis and by inducing pexophagy. Tumor growth was evaluated in subcutaneous xenograft models. Multi-omics analyses, including transcriptomics, proteomics, metabolomics, and lipid profiling, were performed on tumor tissues. Cellular metabolism was assessed using Seahorse extracellular flux analysis in spheroids cultured in human plasma-like medium. Changes in the tumor microenvironment (TME) were evaluated by histological analysis. RESULTS: Peroxisome depletion significantly suppressed ccRCC progression by reducing tumor cell proliferation. It impaired mitochondrial fitness, particularly oxidative phosphorylation, the tricarboxylic acid cycle, and mitochondrial translation. These changes were accompanied by reductions in both glycolytic and mitochondrial flux, resulting in decreased metabolic flexibility and a shift toward a quiescent bioenergetic state that limits tumor growth. Peroxisome-depleted tumors also exhibited oxylipin accumulation. Moreover, peroxisome loss reshaped the TME, as evidenced by increased collagen deposition, enhanced stromal cell infiltration, and a shift in fibroblast populations toward SERPINH1-positive (Serpin Family H Member 1) phenotypes. Consistently, low peroxisome abundance was associated with increased fibrosis in human ccRCC samples. CONCLUSIONS: Peroxisome loss constrains ccRCC progression through coordinated metabolic and microenvironmental alterations. These findings highlight a previously underappreciated role of peroxisomes in regulating metabolic fitness and the TME in ccRCC, and suggest potential therapeutic strategies aimed at targeting peroxisome homeostasis in kidney malignancies.

Schlagwörter

Stichwörter der Autor:innen

OXPHOSccRCCfibrosismitochondriaoxylipinspexophagy

Autor:innen und Institutionen

  • Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland; Present address: Research Center Molecular Biotechnology, Hochschule Campus Wien, University of Applied Sciences, Vienna, Austria.
  • Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
  • Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
  • Institute for Vascular Signalling, Goethe University, Frankfurt am Main, Germany; Department of Histology and Embryology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology,…
  • Center for Medical Research, Medical University of Graz, Graz, Austria.
  • Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland. Electronic address: werner.kovacs@biol.ethz.ch.

Zitieren

APA

Eberhart, T., Orriols, L. M., Suter, V., Castro-Giner, F., Chabbert, C. D., Zhou, J., Zamboni, N., Hu, J., Köfeler, H. C., Aceto, N., & Kovacs, W. J. (2026). Peroxisome depletion suppresses clear cell renal cell carcinoma. Kidney International. https://doi.org/10.1016/j.kint.2026.10.028

Vancouver

Eberhart T, Orriols LM, Suter V, Castro-Giner F, Chabbert CD, Zhou J, et al. Peroxisome depletion suppresses clear cell renal cell carcinoma. Kidney International. 2026. doi:10.1016/j.kint.2026.10.028

BibTeX
@article{Eberhart2026,
  author = {Eberhart, Tanja and Orriols, Lidia Madrigal and Suter, Vanessa and Castro-Giner, Francesc and Chabbert, Christophe D and Zhou, Jianwen and Zamboni, Nicola and Hu, Jiong and Köfeler, Harald C and Aceto, Nicola and Kovacs, Werner J},
  title = {Peroxisome depletion suppresses clear cell renal cell carcinoma},
  journal = {Kidney International},
  year = {2026},
  doi = {10.1016/j.kint.2026.10.028}
}
Kostenlos starten →